BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Westphal M, Lamszus K. Circulating biomarkers for gliomas. Nat Rev Neurol 2015;11:556-66. [PMID: 26369507 DOI: 10.1038/nrneurol.2015.171] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol 2018;15:422-42. [DOI: 10.1038/s41571-018-0003-5] [Cited by in Crossref: 332] [Cited by in F6Publishing: 320] [Article Influence: 83.0] [Reference Citation Analysis]
2 Wang J, Cao Y, Zhang H, Wang T, Tian Q, Lu X, Lu X, Kong X, Liu Z, Wang N, Zhang S, Ma H, Ning S, Wang L. NSDNA: a manually curated database of experimentally supported ncRNAs associated with nervous system diseases. Nucleic Acids Res 2017;45:D902-7. [PMID: 27899613 DOI: 10.1093/nar/gkw1038] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
3 Gambari R, Brognara E, Spandidos DA, Fabbri E. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol 2016;49:5-32. [PMID: 27175518 DOI: 10.3892/ijo.2016.3503] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 18.0] [Reference Citation Analysis]
4 Short SC. Science in Focus: MicroRNA in Glioma - Potential as Biomarkers and Therapeutic Targets. Clin Oncol (R Coll Radiol) 2016;28:543-6. [PMID: 27184942 DOI: 10.1016/j.clon.2016.04.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ye F, Zhao Y, El-sayed R, Muhammed M, Hassan M. Advances in nanotechnology for cancer biomarkers. Nano Today 2018;18:103-23. [DOI: 10.1016/j.nantod.2017.12.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 9.3] [Reference Citation Analysis]
6 Tabibkhooei A, Izadpanahi M, Arab A, Zare-Mirzaei A, Minaeian S, Rostami A, Mohsenian A. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas. Clin Neurol Neurosurg 2020;190:105652. [PMID: 31896490 DOI: 10.1016/j.clineuro.2019.105652] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
7 Kawamura Y, Takouda J, Yoshimoto K, Nakashima K. New aspects of glioblastoma multiforme revealed by similarities between neural and glioblastoma stem cells. Cell Biol Toxicol 2018;34:425-40. [PMID: 29383547 DOI: 10.1007/s10565-017-9420-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
8 Decavèle M, Weiss N, Rivals I, Prodanovic H, Idbaih A, Mayaux J, Similowski T, Demoule A. Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience. J Neurol 2017;264:2303-12. [PMID: 28993874 DOI: 10.1007/s00415-017-8624-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
9 Kan LK, Drummond K, Hunn M, Williams D, O'Brien TJ, Monif M. Potential biomarkers and challenges in glioma diagnosis, therapy and prognosis. BMJ Neurol Open 2020;2:e000069. [PMID: 33681797 DOI: 10.1136/bmjno-2020-000069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Santangelo A, Tamanini A, Cabrini G, Dechecchi MC. Circulating microRNAs as emerging non-invasive biomarkers for gliomas. Ann Transl Med 2017;5:277. [PMID: 28758103 DOI: 10.21037/atm.2017.06.15] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
11 Cheng P, Ma Y, Gao Z, Duan L. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway. Med Sci Monit 2018;24:8916-24. [PMID: 30531692 DOI: 10.12659/MSM.912104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
12 Bergamin LS. P2X7 receptors and glioma cells. Purinergic Signal 2020;16:253-4. [PMID: 32870442 DOI: 10.1007/s11302-020-09725-y] [Reference Citation Analysis]
13 Yu J, Sheng Z, Wu S, Gao Y, Yan Z, Bu C, Gu J, Bu Y, Deng K, Xu S, Chen Z, Zhang Q, Zemmar A, Hernesniemi J, Wang M, Liu G, Li T, Bu X. Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence. Front Oncol 2021;11:742037. [PMID: 34712610 DOI: 10.3389/fonc.2021.742037] [Reference Citation Analysis]
14 Cheng AP, Burnham P, De Vlaminck I. Biopsy-free screening for glioma. EMBO Mol Med 2018;10:e9484. [PMID: 30401728 DOI: 10.15252/emmm.201809484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Prinzing BL, Gottschalk SM, Krenciute G. CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing? Expert Rev Anticancer Ther 2018;18:451-61. [PMID: 29533108 DOI: 10.1080/14737140.2018.1451749] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
16 Jovčevska I. Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma. Front Oncol 2020;10:798. [PMID: 32500035 DOI: 10.3389/fonc.2020.00798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Di Santo R, Quagliarini E, Digiacomo L, Pozzi D, Di Carlo A, Caputo D, Cerrato A, Montone CM, Mahmoudi M, Caracciolo G. Protein corona profile of graphene oxide allows detection of glioblastoma multiforme using a simple one-dimensional gel electrophoresis technique: a proof-of-concept study. Biomater Sci 2021;9:4671-8. [PMID: 34018505 DOI: 10.1039/d1bm00488c] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li L, Mu W, Wang Y, Liu Z, Liu Z, Wang Y, Ma W, Kong Z, Wang S, Zhou X, Wei W, Cheng X, Lin Y, Tian J. A Non-invasive Radiomic Method Using 18F-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma. Front Oncol 2019;9:1183. [PMID: 31803608 DOI: 10.3389/fonc.2019.01183] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
19 Huang Q, Chen H, Zuo B, Cheng C, Yu W, Yang Y. lncRNA NEF inhibits glioma by downregulating TGF-β1. Exp Ther Med 2019;18:692-8. [PMID: 31258706 DOI: 10.3892/etm.2019.7602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Zhu L, Cheng G, Ye D, Nazeri A, Yue Y, Liu W, Wang X, Dunn GP, Petti AA, Leuthardt EC, Chen H. Focused Ultrasound-enabled Brain Tumor Liquid Biopsy. Sci Rep 2018;8:6553. [PMID: 29700310 DOI: 10.1038/s41598-018-24516-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
21 Čuperlović-Culf M, Khieu NH, Surendra A, Hewitt M, Charlebois C, Sandhu JK. Analysis and Simulation of Glioblastoma Cell Lines-Derived Extracellular Vesicles Metabolome. Metabolites 2020;10:E88. [PMID: 32131411 DOI: 10.3390/metabo10030088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
22 Koper-Lenkiewicz OM, Milewska AJ, Kamińska J, Sawicki K, Chrzanowski R, Zińczuk J, Reszeć J, Tylicka M, Matuszczak E, Matowicka-Karna J, Mariak Z, Mucha MW, Pawlak R, Dymicka-Piekarska V. Myelin-associated proteins are potential diagnostic markers in patients with primary brain tumour. Ann Med 2021;53:1710-21. [PMID: 34601991 DOI: 10.1080/07853890.2021.1983205] [Reference Citation Analysis]
23 André-Grégoire G, Gavard J. Spitting out the demons: Extracellular vesicles in glioblastoma. Cell Adh Migr 2017;11:164-72. [PMID: 27736300 DOI: 10.1080/19336918.2016.1247145] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
24 de Trizio I, Errede M, d'Amati A, Girolamo F, Virgintino D. Expression of P-gp in Glioblastoma: What we can Learn from Brain Development. Curr Pharm Des 2020;26:1428-37. [PMID: 32186270 DOI: 10.2174/1381612826666200318130625] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
25 Sol N, In 't Veld SGJG, Vancura A, Tjerkstra M, Leurs C, Rustenburg F, Schellen P, Verschueren H, Post E, Zwaan K, Ramaker J, Wedekind LE, Tannous J, Ylstra B, Killestein J, Mateen F, Idema S, de Witt Hamer PC, Navis AC, Leenders WPJ, Hoeben A, Moraal B, Noske DP, Vandertop WP, Nilsson RJA, Tannous BA, Wesseling P, Reijneveld JC, Best MG, Wurdinger T. Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma. Cell Rep Med 2020;1:100101. [PMID: 33103128 DOI: 10.1016/j.xcrm.2020.100101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
26 Petrescu GED, Sabo AA, Torsin LI, Calin GA, Dragomir MP. MicroRNA based theranostics for brain cancer: basic principles. J Exp Clin Cancer Res 2019;38:231. [PMID: 31142339 DOI: 10.1186/s13046-019-1180-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
27 Noch EK, Ramakrishna R, Magge R. Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance. World Neurosurg 2018;116:505-17. [PMID: 30049045 DOI: 10.1016/j.wneu.2018.04.022] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
28 Wang J, Che F, Zhang J, Zhang M, Xiao S, Liu Y, Zhou L, Su Q, You C, Lu Y, Heng X. Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma. World Neurosurg 2019;125:e1217-25. [PMID: 30794970 DOI: 10.1016/j.wneu.2019.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
29 Huang C, Li H, Powell JS, Ouyang Y, Wendell SG, Suresh S, Hsia KJ, Sadovsky Y, Quinn D. Assessing hypoxic damage to placental trophoblasts by measuring membrane viscosity of extracellular vesicles. Placenta 2022. [DOI: 10.1016/j.placenta.2022.02.019] [Reference Citation Analysis]
30 Zhang DY, Gould A, Happ HC, Youngblood MW, Dmello C, Kang SJ, Canney M, Stupp R, Carvill GL, Sonabend AM. Ultrasound-mediated blood-brain barrier opening increases cell-free DNA in a time-dependent manner. Neurooncol Adv 2021;3:vdab165. [PMID: 34993480 DOI: 10.1093/noajnl/vdab165] [Reference Citation Analysis]
31 Wang J, Bettegowda C. Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms. J Mol Diagn 2017;19:24-34. [PMID: 27863260 DOI: 10.1016/j.jmoldx.2016.08.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
32 Wu D, Wang DC, Cheng Y, Qian M, Zhang M, Shen Q, Wang X. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy. Seminars in Cancer Biology 2017;42:13-9. [DOI: 10.1016/j.semcancer.2016.11.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
33 Yang Y, Du T, Zhang J, Kang T, Luo L, Tao J, Gou Z, Chen S, Du Y, He J, Jiang S, Mao Q, Gou M. A 3D-Engineered Conformal Implant Releases DNA Nanocomplexs for Eradicating the Postsurgery Residual Glioblastoma. Adv Sci (Weinh) 2017;4:1600491. [PMID: 28852611 DOI: 10.1002/advs.201600491] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
34 Sourani A, Saghaei S, Sabouri M, Soleimani M, Dehghani L. A systematic review of extracellular vesicles as non-invasive biomarkers in glioma diagnosis, prognosis, and treatment response monitoring. Mol Biol Rep 2021;48:6971-85. [PMID: 34460059 DOI: 10.1007/s11033-021-06687-1] [Reference Citation Analysis]
35 Peng J, Liang Q, Xu Z, Cai Y, Peng B, Li J, Zhang W, Kang F, Hong Q, Yan Y, Zhang M. Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses. Front Immunol 2021;12:813747. [PMID: 35095909 DOI: 10.3389/fimmu.2021.813747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Mouliere F, Smith CG, Heider K, Su J, van der Pol Y, Thompson M, Morris J, Wan JCM, Chandrananda D, Hadfield J, Grzelak M, Hudecova I, Couturier DL, Cooper W, Zhao H, Gale D, Eldridge M, Watts C, Brindle K, Rosenfeld N, Mair R. Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients. EMBO Mol Med 2021;13:e12881. [PMID: 34291583 DOI: 10.15252/emmm.202012881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Cheng J, Meng J, Zhu L, Peng Y. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications. Mol Cancer. 2020;19:66. [PMID: 32213181 DOI: 10.1186/s12943-020-01189-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 61] [Article Influence: 27.0] [Reference Citation Analysis]
38 Bertolini I, Terrasi A, Martelli C, Gaudioso G, Di Cristofori A, Storaci AM, Formica M, Braidotti P, Todoerti K, Ferrero S, Caroli M, Ottobrini L, Vaccari T, Vaira V. A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes. EBioMedicine 2019;41:225-35. [PMID: 30737083 DOI: 10.1016/j.ebiom.2019.01.051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
39 Goutnik M, Lucke-Wold B. Commentary: Evaluating potential glioma serum biomarkers, with future applications. World J Clin Oncol 2022; 13(5): 412-416 [DOI: 10.5306/wjco.v13.i5.412] [Reference Citation Analysis]
40 Śledzińska P, Bebyn MG, Furtak J, Kowalewski J, Lewandowska MA. Prognostic and Predictive Biomarkers in Gliomas. Int J Mol Sci 2021;22:10373. [PMID: 34638714 DOI: 10.3390/ijms221910373] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Benecke L, Coray M, Umbricht S, Chiang D, Figueiró F, Muller L. Exosomes: Small EVs with Large Immunomodulatory Effect in Glioblastoma. Int J Mol Sci 2021;22:3600. [PMID: 33808435 DOI: 10.3390/ijms22073600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Xu Y, Xu W, Lu T, Dai Y, Liang W. miR-126 affects the invasion and migration of glioma cells through GATA4. Artif Cells Nanomed Biotechnol 2017;45:1-7. [PMID: 27598297 DOI: 10.1080/21691401.2016.1226179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
43 Müller Bark J, Kulasinghe A, Chua B, Day BW, Punyadeera C. Circulating biomarkers in patients with glioblastoma. Br J Cancer 2020;122:295-305. [PMID: 31666668 DOI: 10.1038/s41416-019-0603-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
44 [DOI: 10.1101/758441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Gareev IF, Novicova LB, Beylerli OA. [Circulating microrPas as new potential biomarkers for the diagnosis of high-grade gliomas]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:86-90. [PMID: 31317895 DOI: 10.17116/jnevro201911905186] [Reference Citation Analysis]
46 Gao T, Gu G, Tian J, Zhang R, Zheng X, Wang Y, Pang Q, Liu Q. LncRNA HSP90AA1-IT1 promotes gliomas by targeting miR-885-5p-CDK2 pathway. Oncotarget 2017;8:75284-97. [PMID: 29088865 DOI: 10.18632/oncotarget.20777] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
47 Bergamin LS, Figueiró F, Dietrich F, Manica FM, Filippi-Chiela EC, Mendes FB, Jandrey EHF, Lopes DV, Oliveira FH, Nascimento IC, Ulrich H, Battastini AMO. Interference of ursolic acid treatment with glioma growth: An in vitro and in vivo study. Eur J Pharmacol 2017;811:268-75. [PMID: 28663034 DOI: 10.1016/j.ejphar.2017.06.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
48 Del Bene M, Osti D, Faletti S, Beznousenko GV, DiMeco F, Pelicci G. Extracellular vesicles: the key for precision medicine in glioblastoma. Neuro Oncol 2021:noab229. [PMID: 34581817 DOI: 10.1093/neuonc/noab229] [Reference Citation Analysis]
49 Treps L, Perret R, Edmond S, Ricard D, Gavard J. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles. J Extracell Vesicles 2017;6:1359479. [PMID: 28815003 DOI: 10.1080/20013078.2017.1359479] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 21.2] [Reference Citation Analysis]
50 Barbaro M, Fine HA, Magge RS. Scientific and Clinical Challenges within Neuro-Oncology. World Neurosurg 2021;151:402-10. [PMID: 33610863 DOI: 10.1016/j.wneu.2021.01.151] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Jonsson P, Antti H, Späth F, Melin B, Björkblom B. Identification of Pre-Diagnostic Metabolic Patterns for Glioma Using Subset Analysis of Matched Repeated Time Points. Cancers (Basel) 2020;12:E3349. [PMID: 33198241 DOI: 10.3390/cancers12113349] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Song Y, Fan J, Li X, Liang X, Wang S. pH‐Regulated Heterostructure Porous Particles Enable Similarly Sized Protein Separation. Adv Mater 2019;31:1900391. [DOI: 10.1002/adma.201900391] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
53 He J, Jiang Y, Liu L, Zuo Z, Zeng C. Circulating MicroRNAs as Promising Diagnostic Biomarkers for Patients With Glioma: A Meta-Analysis. Front Neurol 2020;11:610163. [PMID: 33597912 DOI: 10.3389/fneur.2020.610163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Tan W, Xie X, Li L, Tang H, Ye X, Chen L, Tang W, Gao J, Pan L, Zhang X, Ye F, Li X, Yang L, Xie X, Zheng W. Diagnostic and prognostic value of serum MACC1 in breast cancer patients. Oncotarget 2016;7:84408-15. [PMID: 27793048 DOI: 10.18632/oncotarget.12910] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
55 Zhao Z, Zhang C, Li M, Shen Y, Feng S, Liu J, Li F, Hou L, Chen Z, Jiang J, Ma X, Chen L, Yu X. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas. Jpn J Clin Oncol 2020;50:325-32. [PMID: 32039443 DOI: 10.1093/jjco/hyz156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
56 Ortiz R, Perazzoli G, Cabeza L, Jiménez-Luna C, Luque R, Prados J, Melguizo C. Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications. Curr Neuropharmacol 2021;19:513-37. [PMID: 32589560 DOI: 10.2174/1570159X18666200626204005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
57 Shi J, Zhang Y, Yao B, Sun P, Hao Y, Piao H, Zhao X. Role of Exosomes in the Progression, Diagnosis, and Treatment of Gliomas. Med Sci Monit 2020;26:e924023. [PMID: 33245712 DOI: 10.12659/MSM.924023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
58 Bi Y, Mao Y, Su Z, Du J, Ye L, Xu F. Long noncoding RNA HNF1A-AS1 regulates proliferation and apoptosis of glioma through activation of the JNK signaling pathway via miR-363-3p/MAP2K4. J Cell Physiol 2021;236:1068-82. [PMID: 32779194 DOI: 10.1002/jcp.29916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
59 Zhou L, Gao M, Fu W, Wang Y, Luo D, Chang K, Chen M. Three-dimensional DNA tweezers serve as modular DNA intelligent machines for detection and regulation of intracellular microRNA. Sci Adv 2020;6:eabb0695. [PMID: 32524004 DOI: 10.1126/sciadv.abb0695] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
60 Sorokin M, Raevskiy M, Zottel A, Šamec N, Skoblar Vidmar M, Matjašič A, Zupan A, Mlakar J, Suntsova M, Kuzmin DV, Buzdin A, Jovčevska I. Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma. Cancers (Basel) 2021;13:3419. [PMID: 34298634 DOI: 10.3390/cancers13143419] [Reference Citation Analysis]
61 Lavanya C, Sibin MK, Srinivas Bharath MM, Manoj MJ, Venkataswamy MM, Bhat DI, Narasinga Rao KV, Chetan GK. RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells. Cytotechnology 2016;68:2311-21. [PMID: 27757712 DOI: 10.1007/s10616-016-0025-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. J Exp Clin Cancer Res 2016;35:124. [PMID: 27476114 DOI: 10.1186/s13046-016-0393-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
63 Malara N, Guzzi G, Mignogna C, Trunzo V, Camastra C, Della Torre A, Di Vito A, Lavecchia AM, Gliozzi M, Ceccotti C, Volpentesta G, Lavano A, Donato G, Mollace V. Non-invasive real-time biopsy of intracranial lesions using short time expanded circulating tumor cells on glass slide: report of two cases. BMC Neurol 2016;16:127. [PMID: 27502239 DOI: 10.1186/s12883-016-0652-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
64 Bunevicius A, Deltuva VP, Tamasauskas S, Smith T, Laws ER, Bunevicius R, Iervasi G, Tamasauskas A. Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients. Oncotarget 2017;8:8648-56. [PMID: 28055959 DOI: 10.18632/oncotarget.14376] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
65 Steponaitis G, Skiriutė D, Kazlauskas A, Golubickaitė I, Stakaitis R, Tamašauskas A, Vaitkienė P. High CHI3L1 expression is associated with glioma patient survival. Diagn Pathol 2016;11:42. [PMID: 27121858 DOI: 10.1186/s13000-016-0492-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
66 Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics. Cells 2019;8:E863. [PMID: 31405017 DOI: 10.3390/cells8080863] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 20.7] [Reference Citation Analysis]
67 Verheul C, Kleijn A, Lamfers MLM. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system. Handb Clin Neurol 2017;146:139-69. [PMID: 29110768 DOI: 10.1016/B978-0-12-804279-3.00010-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
68 García-Romero N, Madurga R, Rackov G, Palacín-Aliana I, Núñez-Torres R, Asensi-Puig A, Carrión-Navarro J, Esteban-Rubio S, Peinado H, González-Neira A, González-Rumayor V, Belda-Iniesta C, Ayuso-Sacido A. Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation. J Transl Med 2019;17:75. [PMID: 30871557 DOI: 10.1186/s12967-019-1825-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
69 Koper-Lenkiewicz OM, Kamińska J, Milewska A, Sawicki K, Jadeszko M, Mariak Z, Reszeć J, Dymicka-Piekarska V, Matowicka-Karna J. Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor. BMC Cancer 2019;19:319. [PMID: 30953468 DOI: 10.1186/s12885-019-5525-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
70 Torres Vidal A, Medintz IL, Bui H. DNA Microsystems for Biodiagnosis. Micromachines (Basel) 2020;11:E445. [PMID: 32340280 DOI: 10.3390/mi11040445] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Silva VKA, Rodrigues ML, May RC. Deciphering Fungal Extracellular Vesicles: From Cell Biology to Pathogenesis. Curr Clin Micro Rpt 2019;6:89-97. [DOI: 10.1007/s40588-019-00128-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
72 Santangelo A, Imbrucè P, Gardenghi B, Belli L, Agushi R, Tamanini A, Munari S, Bossi AM, Scambi I, Benati D, Mariotti R, Di Gennaro G, Sbarbati A, Eccher A, Ricciardi GK, Ciceri EM, Sala F, Pinna G, Lippi G, Cabrini G, Dechecchi MC. A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker. J Neurooncol 2018;136:51-62. [PMID: 29076001 DOI: 10.1007/s11060-017-2639-x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
73 Xu P, Yang J, Liu J, Yang X, Liao J, Yuan F, Xu Y, Liu B, Chen Q. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis. BMC Med Genomics 2018;11:96. [PMID: 30382873 DOI: 10.1186/s12920-018-0407-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
74 Rooj AK, Mineo M, Godlewski J. MicroRNA and extracellular vesicles in glioblastoma: small but powerful. Brain Tumor Pathol 2016;33:77-88. [PMID: 26968172 DOI: 10.1007/s10014-016-0259-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
75 Wang J, Che F, Zhang J. Cell-free microRNAs as non-invasive biomarkers in glioma: a diagnostic meta-analysis. Int J Biol Markers 2019;34:232-42. [DOI: 10.1177/1724600819840033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Zhang S, An X, Huang S, Zeng L, Xu Y, Su D, Qu Y, Tang X, Ma J, Yang J, Ai J. AhR/miR-23a-3p/PKCα axis contributes to memory deficits in ovariectomized and normal aging female mice. Mol Ther Nucleic Acids 2021;24:79-91. [PMID: 33738140 DOI: 10.1016/j.omtn.2021.02.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Ascierto PA, Brugarolas J, Buonaguro L, Butterfield LH, Carbone D, Daniele B, Ferris R, Fox BA, Galon J, Gridelli C, Kaufman HL, Klebanoff CA, Melero I, Nathan P, Paulos CM, Ruella M, Sullivan R, Zarour H, Puzanov I. Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy). J Immunother Cancer 2018;6:69. [PMID: 29996914 DOI: 10.1186/s40425-018-0377-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
78 Velmanickam L, Jayasooriya V, Vemuri MS, Tida UR, Nawarathna D. Recent advances in dielectrophoresis toward biomarker detection: A summary of studies published between 2014 and 2021. Electrophoresis 2022;43:212-31. [PMID: 34453855 DOI: 10.1002/elps.202100194] [Reference Citation Analysis]
79 Li Z, Ye L, Wang L, Quan R, Zhou Y, Li X. Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients. Ann Diagn Pathol 2020;44:151436. [PMID: 31865249 DOI: 10.1016/j.anndiagpath.2019.151436] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
80 Maas SLN, van Solinge TS, Schnoor R, Yekula A, Senders JT, de Vrij J, Robe P, Carter BS, Balaj L, Arkesteijn GJA, Nolte-'t Hoen ENM, Broekman MLD. Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients. Cancers (Basel) 2020;12:E3297. [PMID: 33171819 DOI: 10.3390/cancers12113297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Zhao Z, Zhang KN, Chai RC, Wang KY, Huang RY, Li GZ, Wang YZ, Chen J, Jiang T. ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme. Dis Markers 2019;2019:1802620. [PMID: 30728876 DOI: 10.1155/2019/1802620] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
82 Ricklefs FL, Maire CL, Reimer R, Dührsen L, Kolbe K, Holz M, Schneider E, Rissiek A, Babayan A, Hille C, Pantel K, Krasemann S, Glatzel M, Heiland DH, Flitsch J, Martens T, Schmidt NO, Peine S, Breakefield XO, Lawler S, Chiocca EA, Fehse B, Giebel B, Görgens A, Westphal M, Lamszus K. Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours. J Extracell Vesicles 2019;8:1588555. [PMID: 30949309 DOI: 10.1080/20013078.2019.1588555] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 13.7] [Reference Citation Analysis]
83 Ampudia-mesias E, El-hadad S, Cameron CS, Wöhrer A, Ströbel T, Saydam N, Saydam O. SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma. Cancers 2022;14:1984. [DOI: 10.3390/cancers14081984] [Reference Citation Analysis]
84 Zachariah MA, Oliveira-Costa JP, Carter BS, Stott SL, Nahed BV. Blood-based biomarkers for the diagnosis and monitoring of gliomas. Neuro Oncol 2018;20:1155-61. [PMID: 29746665 DOI: 10.1093/neuonc/noy074] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
85 O'Neill BE, Hochhalter CB, Carr C, Strong MJ, Ware ML. Advances in Neuro-Oncology Imaging Techniques. Ochsner J 2018;18:236-41. [PMID: 30275788 DOI: 10.31486/toj.17.0062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
86 Testa A, Venturelli E, Brizzi MF. Extracellular Vesicles as a Novel Liquid Biopsy-Based Diagnosis for the Central Nervous System, Head and Neck, Lung, and Gastrointestinal Cancers: Current and Future Perspectives. Cancers (Basel) 2021;13:2792. [PMID: 34205183 DOI: 10.3390/cancers13112792] [Reference Citation Analysis]
87 Moyano AL, Li G, Boullerne AI, Feinstein DL, Hartman E, Skias D, Balavanov R, Breemen RB, Bongarzone ER, Månsson J, Givogri MI. Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients. Journal of Neuroscience Research 2016;94:1579-87. [DOI: 10.1002/jnr.23899] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
88 Boissinot M, King H, Adams M, Higgins J, Shaw G, Ward TA, Steele LP, Tams D, Morton R, Polson E, da Silva B, Droop A, Hayes JL, Martin H, Laslo P, Morrison E, Tomlinson DC, Wurdak H, Bond J, Lawler SE, Short SC. Profiling cytotoxic microRNAs in pediatric and adult glioblastoma cells by high-content screening, identification, and validation of miR-1300. Oncogene 2020;39:5292-306. [PMID: 32555332 DOI: 10.1038/s41388-020-1360-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Zhang T, Brinkley TE, Liu K, Feng X, Marsh AP, Kritchevsky S, Zhou X, Nicklas BJ. Circulating MiRNAs as biomarkers of gait speed responses to aerobic exercise training in obese older adults. Aging (Albany NY) 2017;9:900-13. [PMID: 28301325 DOI: 10.18632/aging.101199] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
90 Lin LL, Liu ZZ, Tian JZ, Zhang X, Zhang Y, Yang M, Zhong HC, Fang W, Wei RX, Hu C. Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma. Front Oncol 2021;11:633024. [PMID: 34026613 DOI: 10.3389/fonc.2021.633024] [Reference Citation Analysis]
91 Yang J, Wang L, Xu Z, Wu L, Liu B, Wang J, Tian D, Xiong X, Chen Q. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme. Front Genet 2020;11:253. [PMID: 32296458 DOI: 10.3389/fgene.2020.00253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
92 Huang C, Xiong Z, Yang Q, Li X. Systematic Analysis of 4-gene Prognostic Signature in Patients with Diffuse Gliomas Based on Gene Expression Profiles. J Cancer 2021;12:4295-306. [PMID: 34093830 DOI: 10.7150/jca.54565] [Reference Citation Analysis]
93 Jovčevska I. Sequencing the next generation of glioblastomas. Crit Rev Clin Lab Sci 2018;55:264-82. [PMID: 29668342 DOI: 10.1080/10408363.2018.1462759] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
94 Tang X, Xu P, Wang B, Luo J, Fu R, Huang K, Dai L, Lu J, Cao G, Peng H, Zhang L, Zhang Z, Chen Q. Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients. Front Oncol 2019;9:812. [PMID: 31508371 DOI: 10.3389/fonc.2019.00812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
95 Governa V, Talbot H, Gonçalves de Oliveira K, Cerezo-Magaña M, Bång-Rudenstam A, Johansson MC, Månsson AS, Forsberg-Nilsson K, Marko-Varga G, Enríquez Pérez J, Darabi A, Malmström J, Bengzon J, Welinder C, Belting M. Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization. Proc Natl Acad Sci U S A 2022;119:e2114456119. [PMID: 35217608 DOI: 10.1073/pnas.2114456119] [Reference Citation Analysis]